On March 10, 2020 FDA announced it was postponing all foreign inspections and on March 18, 2020, only 8 days later, FDA announced it was also stopping all domestic inspections unless mission critical until such time as it is deemed safe for FDA employees and their families as well as the employees of the firms and their families to resume the inspection process.

The FDA announcement can be found here.  As the COVID-19 pandemic further evolves, I am certain that more changes will be made to how the FDA does business under these unprecedented and difficult circumstances.  We will do our best to keep you abreast of how these changes play out.